Table 4.
Mortality up to day 32 in older (≥60 years) medical patients randomised to the anticoagulant fondaparinux or placebo
Variable | Fondaparinux group (n=425) | Placebo group (n=414) |
---|---|---|
Death from any cause: | ||
Fatal pulmonary embolism | 3 | 7 |
Fatal bleeding* | 2 | 1 |
Other causes | 9 | 17 |
Total No (%) | 14 (3) | 25 (6) |
None occurred during study treatment.